TRUE ARTIS raises Rs 11.4 Cr seed for aesthetic surgery
Integrated aesthetic surgery platform TRUE ARTIS has raised Rs 11.4 crore in a seed funding round led by Zeropearl VC. The round also saw participation from Eleven, a diversified business group of Sunil Sachdeva, co-founder of Medanta, and a group of angel investors.
Operators and healthcare investors included Arjun Vaidya, Dhruv Joshi, Ambarish Gupta and Vivek Lohcheb, CBO of PhonePe, along with former senior executives from Airtel and OYO.
Co-founded in 2025 by Ankit Joshi and Sandeep Upadhyay, TRUE ARTIS is an integrated aesthetic surgery platform focused on personalised aesthetic care. The startup brings together plastic and aesthetic surgeons, surgical infrastructure, hospital-grade safety protocols, dedicated recovery facilities and a privacy-focused patient experience.
Its in-house technology platform manages the patient journey from enquiry and consultation through surgery and recovery.
Newsletter
The corridor, every morning.
Funding rounds and cross-border capital moves, one email, five minutes.
The startup offers services across facial aesthetics, breast procedures, body contouring, hair restoration and non-surgical treatments. It currently operates two centres in Delhi and Gurgaon, and claims to have served more than 10,000 clients and completed over 400 surgeries in the past nine months.
Its centres feature operating theatres, surgical and medical equipment, dedicated recovery facilities, ICU backup and private patient suites. TRUE ARTIS also works with a multidisciplinary network of full-time and visiting plastic surgeons, allowing patients to access multiple specialists through a single platform.
The fresh funds will be used to open two new centres in Delhi NCR over the next six to eight months, strengthen surgical and recovery capabilities, expand its network of plastic and aesthetic surgeons, and enhance its technology and patient-care systems.
The startup works with around 20 plastic surgeons across Delhi NCR and reports a 98% client satisfaction rate. It said its first centre has reached EBITDA break-even, while revenue is growing at a double-digit rate month-on-month.
More in Funding
